- Record: found
- Abstract: not found
- Article: not found
Effect of capecitabine maintenance therapy using lower dosage and higher frequency vs observation on disease-free survival among patients with early-stage triple-negative breast cancer who had received standard treatment: the SYSUCC-001 randomized clinical trial
X. WANG, S.S. Wang, H Huang, X Wang, H HUANG, L Cai, L. ZHAO, R.-J. Peng, SS Wang, L. CAI, L Zhao, RJ Peng
2021
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Comments
Comment on this article
Similar content3,397
- Combination of paclitaxel and bevacizumab without or with capecitabine as first-line treatment of HER2-negative locally recurrent or metastatic breast cancer (LR/MBC): First results from a randomized, multicenter, open-label, phase II study of the Dutch Breast Cancer Trialists' Group (BOOG)Authors: Lam